Irish researchers propose safer way to bring AI into healthcare — without giving up control of patient data

Researchers from University Hospital Limerick and the Research Directorate of HSE Mid West argue that hospitals can harness powerful AI while keeping sensitive health information under their own control Hospitals should not have to choose between embracing artificial intelligence and protecting sensitive patient data, according to researchers from University Hospital Limerick and the Research Directorate of … Read more

New Irish Study Suggests Bone Density Scans Could Predict When Osteoporosis Will Develop, and When Patients May Recover.

Researchers in Limerick have developed a new way of using routine bone density scans (DEXA) to predict the age at which someone is likely to develop osteoporosis and when treatment could help them recover from it. Osteoporosis is the most common bone condition and is characterised by reduced bone strength leading to increased fracture (4 … Read more

HRI Annual Report Launched

The Research Directorate was delighted to participate in the recent launch of the Health Research Institute’s Annual Report 2025. The event was hosted by Prof. Alan Donnelly Director of the Health Research Institute, and the report was officially launched by Prof. Kevin Ryan, Vice President for Research and Innovation at UL. The report highlights a … Read more

Study on swallowing solid tablets published by UHL Pharmacy team.

A pharmacy research team at University Hospital Limerick, led by Anne Harnett, has published a qualitative study exploring healthcare professionals’ views on caring for patients who have difficulty swallowing medicines. The study found that healthcare professionals require more education and training, together with appropriate infrastructure, to enable access to evidence-based information for managing patients who … Read more

UHL researchers part of major leukemia study in NEJM

Professor Ruth Clifford and team of the Haematology Department at UHL and their international collaborators have just published a major study in the management of in patients with previously untreated CLL, fixed-duration treatment with venetoclax–obinutuzumab or venetoclax–ibrutinib demonstrating noninferiority to continuous ibrutinib with regard to investigator-assessed progression-free survival.

UL & UHL researchers empower patients to help advance cancer research

Monday, 26 May 2025 The establishment of Limerick’s first cancer ‘biobank’ is a significant milestone for cancer research that could help develop new treatments and better screening for the disease. The biobank – a facility to store and manage biological samples for research purposes – was established in 2022 by both cancer researchers and clinicians … Read more